DUSA Pharmaceuticals To Present At The Rodman & Renshaw 14th Annual Healthcare Conference
WILMINGTON, Mass., Sept. 4, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc. ® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan ® Photodynamic Therapy (PDT), announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the Rodman & Renshaw 14 th Annual Healthcare Conference on Monday, September 10, 2012 at 11:15 a.m. ET at The Waldorf Astoria Hotel in New York City.
Interested parties can click here to access a live webcast of the presentation or visit our website at www.dusapharma.com . An archived version of the presentation will be available on the DUSA website for 90 days following the presentation.
About DUSA PharmaceuticalsDUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan ® PDT technology platform. Levulan ® Kerastick ® (aminolevulinic acid HCl) for Topical Solution, 20% plus blue light illumination using DUSA's BLU-U ® Blue Light Photodynamic Therapy Illuminator is currently approved for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp. DUSA is based in Wilmington, Mass. Please visit our website at www.dusapharma.com .
CONTACT: Chad Rubin Investor Relations Contact The Trout Group LLC 646-378-2947
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV